Indian drugmakers notch cleaner USFDA inspections as global outcomes worsen
Published on: Feb. 22, 2026, 11:18 a.m. | Source: Business Standard
USFDA data show OAI rates for Indian pharma plants falling to 8% by 2025 even as global outcomes worsen, reflecting stronger quality systems, technology adoption and compliance culture
